OTC · OPGN
OpGen, Inc.
Healthcare · Medical - Diagnostics & Research
$23.91
Up+$9.75 (+68.86%)
Updated Sep 16, 2026, 9:59 AM
SID Score
5.0/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 101.62M
- P/E ratio
- 14.85
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 1.28K
- Avg. volume
- 3.65K
Price performance
OPGN price history
1M range · 0 trading sessions · Daily adjusted prices
OPGN does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest OPGN news
The latest Smart Investors Daily articles mentioning OPGN.
Stock researchCompany · Overview
OPGN research
Overview
Company profile and research snapshot.
Company profile
OPGEN INC
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $0.67
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 14, 2023 | HC Wainwright & Co. | Neutral | — |
| Jul 20, 2023 | HC Wainwright & Co. | Buy | — |
| Jun 26, 2023 | HC Wainwright & Co. | Buy | — |
| Jun 21, 2023 | HC Wainwright & Co. | Buy | — |
| May 16, 2023 | HC Wainwright & Co. | Buy | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.

